{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T16:26:26Z","timestamp":1770567986773,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":107,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2020]]},"DOI":"10.6061\/clinics\/2020\/e1515","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:19:11Z","timestamp":1586945951000},"page":"e1515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5399-9178","authenticated-orcid":false,"given":"Yongwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-0671","authenticated-orcid":false,"given":"Huanhuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-4550","authenticated-orcid":false,"given":"Lanfang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.6061\/clinics\/2020\/e1515_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/00325481.2018.1492309","article-title":"Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do?","volume":"130","author":"Zardi","year":"2018","journal-title":"Postgrad Med"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1515_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1515_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1515_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1017\/S0317167100014219","article-title":"Neuropsychiatric lupus: classification criteria in neuroimaging studies","volume":"40","author":"Netto","year":"2013","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1515_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"56","author":"Hanly","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.6061\/clinics\/2020\/e1515_bib6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1515_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2012.08.014","article-title":"Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria","volume":"12","author":"Sciascia","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1515_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1515_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"10.6061\/clinics\/2020\/e1515_bib10","series-title":"Dubois\u2019 Lupus Erythematosus and Related Syndromes","first-page":"363","article-title":"Pathogensesis of the Nervous System","author":"Aranow","year":"2013"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1515_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","article-title":"Inflammatory markers in depression","volume":"22","author":"Dinan","year":"2009","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1515_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/14397595.2015.1083163","article-title":"Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus","volume":"26","author":"Ogawa","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1515_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","article-title":"The blood-brain barrier and immune function and dysfunction","volume":"37","author":"Banks","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1515_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1269","article-title":"The dark side of C5a in sepsis","volume":"4","author":"Ward","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.6061\/clinics\/2020\/e1515_bib15","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.6061\/clinics\/2020\/e1515_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity","year":"2015","journal-title":"BMC Med"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1515_bib17","first-page":"135","article-title":"Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations: European Concerted Action on the Immunogenetics of SLE","volume":"27","author":"Galeazzi","year":"2000","journal-title":"J Rheumatol"},{"key":"10.6061\/clinics\/2020\/e1515_bib18","series-title":"Dubois\u2019 Lupus Erythematosus and Related Syndromes","first-page":"368","article-title":"Clinical aspects of the nervous system","author":"West","year":"2013"},{"issue":"12","key":"10.6061\/clinics\/2020\/e1515_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1590\/0004-282x20160150","article-title":"Neuropsychiatric Lupus in clinical practice","volume":"74","author":"Alessi","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1515_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0961203307085671","article-title":"Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients","volume":"17","author":"Zhou","year":"2008","journal-title":"Lupus"},{"issue":"13","key":"10.6061\/clinics\/2020\/e1515_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/138161208799316401","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach","volume":"14","author":"Sanna","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1515_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002265","article-title":"Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus","author":"Trevisani","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1515_bib23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Braile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1515_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/0961203318772021","article-title":"Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study","volume":"27","author":"Ahn","year":"2018","journal-title":"Lupus"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1515_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.6061\/clinics\/2020\/e1515_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2015.01.010","article-title":"Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: Factors associated with accrual of damage and central nervous system involvement","volume":"14","author":"Piga","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1515_bib27","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/art.38106","article-title":"Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study","volume":"65","author":"Hanly","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1515_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","article-title":"Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients","volume":"13","author":"Petri","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.6061\/clinics\/2020\/e1515_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0961203309106174","article-title":"Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases","volume":"18","author":"Ramos-Casals","year":"2009","journal-title":"Lupus"},{"key":"10.6061\/clinics\/2020\/e1515_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","article-title":"Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier","volume":"91","author":"Gelb","year":"2018","journal-title":"J Autoimmun"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1515_bib31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.autrev.2014.04.002","article-title":"Neuropsychiatric systemic lupus erythematosus: tools for the diagnosis","volume":"13","author":"Zardi","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:59:03Z","timestamp":1761721143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222003039"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322020000100406&lng=en&nrm=iso","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7153357\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/neuropsychiatric-lupus-erythematosus-future-directions-and-challenges-a-systematic-review-and-survey\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":31,"alternative-id":["S1807593222003039"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1515","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e1515"}}